Evidence-based organ-sparing radiotherapy in head and neck cancer.
about
De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinomaNon-surgical interventions for human papilloma virus-positive local advanced oropharyngeal squamous cell cancerStem cell therapies for the treatment of radiation-induced normal tissue side effects.Emerging drugs to treat squamous cell carcinomas of the head and neck.Brain-sparing methods for IMRT of head and neck cancer.Multicriteria optimization enables less experienced planners to efficiently produce high quality treatment plans in head and neck cancer radiotherapyThe potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literatureA pilot prospective feasibility study of organ-at-risk definition using Target Contour Testing/Instructional Computer Software (TaCTICS), a training and evaluation platform for radiotherapy target delineation.Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.Regional recurrence of oropharyngeal cancer after definitive radiotherapy: a case control study.Safety and Efficacy of Botulinum Toxin to Preserve Gland Function after Radiotherapy in Patients with Head and Neck Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blinded Phase I Clinical TrialRobust Intensity Modulated Proton Therapy (IMPT) Increases Estimated Clinical Benefit in Head and Neck Cancer Patients.New approaches to EGFR inhibition for locally advanced or metastatic squamous cell carcinoma of the head and neck (SCCHN).Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy.Noncancer-Related Health Events and Mortality in Head and Neck Cancer Patients After Definitive Radiotherapy: A Prospective StudyIMRT for head and neck cancer: reducing xerostomia and dysphagia.Clinical value of monoclonal antibodies and tyrosine kinase inhibitors in the treatment of head and neck squamous cell carcinoma.Radiotherapy for laryngeal squamous cell carcinoma: current standards.Organ-sparing radiation therapy for head and neck cancer.3D Variation in delineation of head and neck organs at risk.Sparing functional anatomical structures during intensity-modulated radiotherapy: an old problem, a new solution.Emerging tyrosine kinase inhibitors for head and neck cancer.The potential of helical tomotherapy in the treatment of head and neck cancer.Valid and reliable techniques for measuring fibrosis in patients with head and neck cancer postradiotherapy: A systematic review.Volumetric modulated arc therapy for treatment of solid tumors: current insights.Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.Nasopharyngeal carcinoma in a low incidence European area : A prospective observational analysis from the Head and Neck Study Group of the Italian Society of Radiation Oncology (AIRO).Sparing the contralateral submandibular gland without compromising PTV coverage by using volumetric modulated arc therapy.Radiation-induced acute dysphagia : Prospective observational study on 42 head and neck cancer patients.RapidArc, SmartArc and TomoHD compared with classical step and shoot and sliding window intensity modulated radiotherapy in an oropharyngeal cancer treatment plan comparison.Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: is there a place for critical swallowing structures dose sparing?Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer.Does hyperbaric oxygen therapy have the potential to improve salivary gland function in irradiated head and neck cancer patients?The future of predictive models in radiation oncology: from extensive data mining to reliable modeling of the results.Emerging drugs for head and neck cancer.Segmentation of organs-at-risks in head and neck CT images using convolutional neural networks.Survival and quality of life in oropharyngeal cancer patients treated with primary chemoradiation after salivary gland transfer.Delineation of the larynx as organ at risk in radiotherapy: a contouring course within "Rete Oncologica Piemonte-Valle d'Aosta" network to reduce inter- and intraobserver variability.Relationship between xerostomia and gingival condition in young adults.Temporally feathered intensity modulated radiation therapy: a planning technique to reduce normal tissue toxicity.
P2860
Q24200362-A708EACE-0466-4456-BEFD-1BBF12439B5CQ24202687-D934B1FB-930D-4EF1-A925-5B2A71D36E8AQ33768112-27CDDBDD-280E-446A-A52F-C029A44CAB57Q35098322-AE84DA35-D56A-4794-8410-2BBE33EBDEC7Q35190988-FCB326BA-E7FE-4844-A88A-BB607A10B6B9Q35427311-D692A32E-DEAE-4F4C-B212-242A9FC2B884Q35584522-8E22D350-1B57-459F-9B3F-C37B6639F7E5Q35625117-12F52930-2F4D-45FB-ACEE-E8FC2D1B8C48Q35673572-F50C4754-4F52-48CC-8118-BA8571BB2B7DQ35814887-C5921326-E731-4573-A81F-575E789247BFQ35962741-133E64EF-FD3C-44C7-BE05-24DD748AC83BQ35974874-BDE7D393-0AB0-4E86-BCDA-532A909E30FAQ36303845-F87D7D21-93E2-4C62-8DA3-CD22ACF93389Q36626509-10E16F78-F560-4A35-A81C-E9B4464DF65FQ36993334-802FEA1B-E679-4B38-B017-82B4468180E8Q37187245-72381B6A-BE0A-45E9-90DF-975A3D56047FQ37709902-CA0DD1DE-12B6-464D-8A8E-11F111A086F7Q37788244-8D70D46A-C4B0-445D-89BB-59DB3F13A824Q37905536-007E026B-2137-4D87-880A-3CD8A5B1F796Q37993227-F18A2513-C269-4096-8E87-DFB7973C2F3FQ38132448-CB25ACC2-7404-444A-897F-E4F3232B3623Q38149327-052C49D0-5A5E-4882-A0BE-EEBF4CD99DDAQ38426070-68853E2D-7769-437E-A2D6-926721EEA108Q38631063-808A84E4-BDAF-418A-96BF-8FDA5F1CF2E3Q38631481-25B9B5CA-13A4-4E69-9882-C24EDAC3F572Q38713948-8A0CC007-3881-4391-AB63-61497FCC0391Q39268762-2E936545-BAE7-4794-9F4A-65ED97DF58ECQ39738530-93F785D8-93DF-4B8B-8DE6-A00BBF2E13DFQ40051688-8FA0C00F-D85B-43A9-985C-F84C4CCD5994Q41033896-3032D48B-503D-4398-8295-425896499096Q41757990-C890A53F-DC2D-4D46-BE65-7DC47404C5A3Q41897016-60A0CB84-A1D9-4176-897E-6854446240DEQ42554100-D913938D-201F-42D3-B748-F167AAD5EA94Q44073308-8666993F-68B3-4CBF-BD66-47CE7009B321Q45874449-83406458-744E-433E-8173-294263EB5509Q45986575-471B22EC-0E9E-4728-B4B6-B6743CBFD799Q47716257-980E8CC6-B760-47D5-B75C-269197DF6BC7Q48157099-409437D7-76E9-438A-8514-DCC56401D188Q50702664-8A92A315-8C15-49D0-82AF-DAAEF1A9A67CQ54203051-59995CBC-7208-4BEB-864B-2537DC76943A
P2860
Evidence-based organ-sparing radiotherapy in head and neck cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evidence-based organ-sparing radiotherapy in head and neck cancer.
@en
Evidence-based organ-sparing radiotherapy in head and neck cancer.
@nl
type
label
Evidence-based organ-sparing radiotherapy in head and neck cancer.
@en
Evidence-based organ-sparing radiotherapy in head and neck cancer.
@nl
prefLabel
Evidence-based organ-sparing radiotherapy in head and neck cancer.
@en
Evidence-based organ-sparing radiotherapy in head and neck cancer.
@nl
P1433
P1476
Evidence-based organ-sparing radiotherapy in head and neck cancer.
@en
P2093
Piet Dirix
Sandra Nuyts
P356
10.1016/S1470-2045(09)70231-1
P577
2010-01-01T00:00:00Z